Patents by Inventor Leon WAN

Leon WAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240366519
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Application
    Filed: July 15, 2022
    Publication date: November 7, 2024
    Applicant: Celator Pharmaceuticals, Inc.
    Inventors: Leon WAN, Winnie LUI, Paul TARDI, Lawrence MAYER
  • Publication number: 20240350411
    Abstract: Provided herein are methods of purifying liposomal formulations by washing with acidic aqueous solutions.
    Type: Application
    Filed: July 15, 2022
    Publication date: October 24, 2024
    Inventors: Paul TARDI, Leon WAN, Shyam Madhusudan GARG, Jun GAO, Philippe LEGROS
  • Publication number: 20230059528
    Abstract: Provided herein are liposomes comprising B-cell lymphoma (Bcl) protein inhibitors, compositions comprising such liposomes, and methods using such formulations for treating hyperproliferative disorders.
    Type: Application
    Filed: July 15, 2022
    Publication date: February 23, 2023
    Applicant: Celator Pharmaceuticals, Inc.
    Inventors: Paul TARDI, Leon Wan, Shyam Madhusudan Garg, Jun Gao, Philippe Legros
  • Patent number: 11413253
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: August 16, 2022
    Assignee: Celator Pharmaceuticals, Inc.
    Inventors: Leon Wan, Winnie Lui, Paul Tardi, Lawrence Mayer
  • Publication number: 20210052508
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Application
    Filed: September 4, 2020
    Publication date: February 25, 2021
    Applicant: Celator Pharmaceuticals, Inc.
    Inventors: Leon WAN, Winnie LUI, Paul TARDI, Lawrence MAYER
  • Publication number: 20190209484
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Application
    Filed: March 15, 2019
    Publication date: July 11, 2019
    Applicant: CELATOR PHARMACEUTICALS, INC.
    Inventors: Leon WAN, Winnie LUI, Paul TARDI, Lawrence MAYER
  • Patent number: 10285951
    Abstract: Nanoparticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: May 14, 2019
    Assignee: CELATOR PHARMACEUTICALS, INC.
    Inventors: Leon Wan, Winnie Lui, Paul Tardi, Lawrence Mayer
  • Publication number: 20180207104
    Abstract: Nanopaiticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.
    Type: Application
    Filed: July 14, 2016
    Publication date: July 26, 2018
    Applicant: CELATOR PHARMACEUTICALS, INC.
    Inventors: Leon WAN, Winnie LUI, Paul TARDI, Lawrence MAYER